← Back to All Filings

ICON plc Director Dr. John Climax Exercises Options and Sells $875.8K in Shares

Low SignificanceSeptember 18, 2026 at 11:08:26 AM UTC

ICON PLC

$ICLR4CIK: 0001060955

Subscribe to track ICLR

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

# Insider Trade Alert: ICON PLC ($ICLR)
**Insider:** CLIMAX JOHN DR (Director)
**Type:** Option Exercise & Sale
**Date:** 2026-09-16
**Shares Sold:** 5,005 @ $175.00
**Total Sale Value:** $875,875
**Remaining Holdings:** 2,087 shares

Comprehensive Analysis

Overview

On September 16, 2026, Dr. John Climax, a Director at ICON PLC ($ICLR), executed a routine option exercise and disposition of Ordinary Shares. The filing was submitted to the SEC on September 18, 2026.

Transaction Breakdown

  • Option Exercise: Dr. Climax exercised 5,005 stock options with an exercise price of $125.74 per share (transaction code M).
  • Open Market Sale: On the same day, Dr. Climax sold all 5,005 underlying Ordinary Shares at a price of $175.00 per share (transaction code S), generating gross proceeds of $875,875.
  • Net Holdings: Following the sale, Dr. Climax retains direct ownership of 2,087 Ordinary Shares.

Context & Significance

This transaction represents a classic cashless or exercise-and-sell transaction. The options, originally granted on May 18, 2018, were reaching their eight-year expiration term. Because the sale was directly paired with the exercise of maturing options rather than a divestment of base long-term share holdings, it carries Low predictive significance regarding future corporate performance.

Topics:#ICLR#ICON#InsiderTrading#StockMarket#BioTech

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.